JP2017531619A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531619A5
JP2017531619A5 JP2017513061A JP2017513061A JP2017531619A5 JP 2017531619 A5 JP2017531619 A5 JP 2017531619A5 JP 2017513061 A JP2017513061 A JP 2017513061A JP 2017513061 A JP2017513061 A JP 2017513061A JP 2017531619 A5 JP2017531619 A5 JP 2017531619A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
polymorph
stereoisomer
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017513061A
Other languages
English (en)
Japanese (ja)
Other versions
JP6732736B2 (ja
JP2017531619A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/072551 external-priority patent/WO2016050841A1/en
Publication of JP2017531619A publication Critical patent/JP2017531619A/ja
Publication of JP2017531619A5 publication Critical patent/JP2017531619A5/ja
Application granted granted Critical
Publication of JP6732736B2 publication Critical patent/JP6732736B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017513061A 2014-10-01 2015-09-30 デングウィルス複製阻害剤としての一または二置換インドール誘導体 Active JP6732736B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14187374 2014-10-01
EP14187374.5 2014-10-01
EP15159164 2015-03-16
EP15159164.1 2015-03-16
PCT/EP2015/072551 WO2016050841A1 (en) 2014-10-01 2015-09-30 Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Publications (3)

Publication Number Publication Date
JP2017531619A JP2017531619A (ja) 2017-10-26
JP2017531619A5 true JP2017531619A5 (cg-RX-API-DMAC7.html) 2018-11-08
JP6732736B2 JP6732736B2 (ja) 2020-07-29

Family

ID=54199687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017513061A Active JP6732736B2 (ja) 2014-10-01 2015-09-30 デングウィルス複製阻害剤としての一または二置換インドール誘導体

Country Status (32)

Country Link
US (1) US9944598B2 (cg-RX-API-DMAC7.html)
EP (1) EP3201176B1 (cg-RX-API-DMAC7.html)
JP (1) JP6732736B2 (cg-RX-API-DMAC7.html)
KR (1) KR102478311B1 (cg-RX-API-DMAC7.html)
CN (1) CN107001264B (cg-RX-API-DMAC7.html)
AU (1) AU2015326930B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017006299A2 (cg-RX-API-DMAC7.html)
CA (1) CA2959573A1 (cg-RX-API-DMAC7.html)
CL (1) CL2017000782A1 (cg-RX-API-DMAC7.html)
CY (1) CY1121874T1 (cg-RX-API-DMAC7.html)
DK (1) DK3201176T3 (cg-RX-API-DMAC7.html)
EA (1) EA032546B1 (cg-RX-API-DMAC7.html)
ES (1) ES2714074T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20190199T1 (cg-RX-API-DMAC7.html)
HU (1) HUE041888T2 (cg-RX-API-DMAC7.html)
IL (1) IL251396A0 (cg-RX-API-DMAC7.html)
LT (1) LT3201176T (cg-RX-API-DMAC7.html)
MA (1) MA40768B1 (cg-RX-API-DMAC7.html)
ME (1) ME03360B (cg-RX-API-DMAC7.html)
MX (1) MX2017004299A (cg-RX-API-DMAC7.html)
PH (1) PH12017500571A1 (cg-RX-API-DMAC7.html)
PL (1) PL3201176T3 (cg-RX-API-DMAC7.html)
PT (1) PT3201176T (cg-RX-API-DMAC7.html)
RS (1) RS58461B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201702463YA (cg-RX-API-DMAC7.html)
SI (1) SI3201176T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900162T1 (cg-RX-API-DMAC7.html)
TW (1) TWI681951B (cg-RX-API-DMAC7.html)
UA (1) UA121119C2 (cg-RX-API-DMAC7.html)
UY (1) UY36340A (cg-RX-API-DMAC7.html)
WO (1) WO2016050841A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201702301B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
RU2717558C2 (ru) 2014-10-01 2020-03-24 Мерк Патент Гмбх Производные бороновой кислоты
KR102478309B1 (ko) * 2014-10-01 2022-12-15 얀센 파마슈티칼즈, 인코포레이티드 뎅기 바이러스 복제 억제제로서의 1치환 또는 2치환 인돌
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
AU2017242893A1 (en) 2016-03-31 2018-08-09 Janssen Pharmaceuticals, Inc. Substituted indole derivatives as dengue viral replication inhibitors
KR102359735B1 (ko) * 2016-03-31 2022-02-08 얀센 파마슈티칼즈, 인코포레이티드 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체
CN109069482B (zh) * 2016-04-01 2022-04-05 杨森制药公司 作为登革热病毒复制抑制剂的经取代的吲哚化合物衍生物
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
BR112019024195A2 (pt) * 2017-05-22 2020-06-23 Janssen Pharmaceuticals, Inc. Composto e composição farmacêutica de derivados de indolina substituídos como inibidores da replicação viral da dengue
WO2018215316A1 (en) 2017-05-22 2018-11-29 Janssen Pharmaceuticals, Inc. Substituted indoline derivatives as dengue viral replication inhibitors
WO2024252254A1 (en) * 2023-06-05 2024-12-12 Zydus Lifesciences Limited Novel compounds to treat viral infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011002635A1 (en) * 2009-06-30 2011-01-06 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
GB201116559D0 (en) * 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
JOP20160086B1 (ar) * 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar) * 2015-09-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك

Similar Documents

Publication Publication Date Title
JP2017531619A5 (cg-RX-API-DMAC7.html)
JP2019510034A5 (cg-RX-API-DMAC7.html)
JP2019510027A5 (cg-RX-API-DMAC7.html)
JP2019501879A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
JP2018515495A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2017523225A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
HRP20200408T1 (hr) Mono- ili di-supstituirani derivati indola kao inhibitori replikacije denga virusa
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2013518107A5 (cg-RX-API-DMAC7.html)
JP2020097577A5 (cg-RX-API-DMAC7.html)
JP2017514910A5 (cg-RX-API-DMAC7.html)
JP2017517565A5 (cg-RX-API-DMAC7.html)
JP2009504763A5 (cg-RX-API-DMAC7.html)
JP2013010792A5 (cg-RX-API-DMAC7.html)
JP2015508103A5 (cg-RX-API-DMAC7.html)
JP2014521688A5 (cg-RX-API-DMAC7.html)
JP2017526677A5 (cg-RX-API-DMAC7.html)
JP2019526596A5 (cg-RX-API-DMAC7.html)
HRP20210847T1 (hr) Supstituirani derivati indola kao inhibitori replikacije denga virusa
JP2014532716A5 (cg-RX-API-DMAC7.html)